TW200607493A - Potassium channel inhibitors - Google Patents
Potassium channel inhibitorsInfo
- Publication number
- TW200607493A TW200607493A TW094125011A TW94125011A TW200607493A TW 200607493 A TW200607493 A TW 200607493A TW 094125011 A TW094125011 A TW 094125011A TW 94125011 A TW94125011 A TW 94125011A TW 200607493 A TW200607493 A TW 200607493A
- Authority
- TW
- Taiwan
- Prior art keywords
- potassium channel
- channel inhibitors
- inhibitors
- compounds
- useful
- Prior art date
Links
- 102000004257 Potassium Channel Human genes 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 108020001213 potassium channel Proteins 0.000 title abstract 2
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59218104P | 2004-07-29 | 2004-07-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200607493A true TW200607493A (en) | 2006-03-01 |
Family
ID=35613661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094125011A TW200607493A (en) | 2004-07-29 | 2005-07-22 | Potassium channel inhibitors |
Country Status (15)
| Country | Link |
|---|---|
| KR (1) | KR20070043985A (zh) |
| AR (1) | AR049847A1 (zh) |
| BR (1) | BRPI0513793A (zh) |
| CR (1) | CR8876A (zh) |
| EC (1) | ECSP077208A (zh) |
| IL (1) | IL180846A0 (zh) |
| MA (1) | MA28980B1 (zh) |
| MX (1) | MX2007001188A (zh) |
| NO (1) | NO20071107L (zh) |
| PE (1) | PE20060382A1 (zh) |
| RU (1) | RU2344134C2 (zh) |
| TW (1) | TW200607493A (zh) |
| UA (1) | UA88018C2 (zh) |
| WO (1) | WO2006028590A1 (zh) |
| ZA (1) | ZA200700477B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2539398C2 (ru) * | 2009-03-18 | 2015-01-20 | Медикю Интернэшинал Инк. | Трансдермальный фармацевтический препарат и введение тирофибана |
| NZ703632A (en) | 2012-06-11 | 2016-01-29 | Bristol Myers Squibb Co | Phosphoramidic acid prodrugs of 5-[5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamide |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2140865B2 (de) * | 1971-08-14 | 1979-10-11 | Bayer Ag, 5090 Leverkusen | 1 -Imidazolyl-methanphosphonsäureester, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
| DE19951701A1 (de) * | 1999-10-27 | 2001-05-03 | Aventis Pharma Gmbh | Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten |
| US7208527B2 (en) * | 2002-01-04 | 2007-04-24 | Poseidon Pharmaceuticals A/S | Potassium channel modulators |
-
2005
- 2005-07-19 AR ARP050102975A patent/AR049847A1/es unknown
- 2005-07-22 PE PE2005000858A patent/PE20060382A1/es not_active Application Discontinuation
- 2005-07-22 TW TW094125011A patent/TW200607493A/zh unknown
- 2005-07-25 WO PCT/US2005/026334 patent/WO2006028590A1/en active Application Filing
- 2005-07-25 MX MX2007001188A patent/MX2007001188A/es unknown
- 2005-07-25 BR BRPI0513793-4A patent/BRPI0513793A/pt not_active IP Right Cessation
- 2005-07-25 RU RU2007107408/04A patent/RU2344134C2/ru not_active IP Right Cessation
- 2005-07-25 UA UAA200702125A patent/UA88018C2/ru unknown
- 2005-07-25 KR KR1020077002228A patent/KR20070043985A/ko not_active Withdrawn
-
2007
- 2007-01-16 ZA ZA200700477A patent/ZA200700477B/xx unknown
- 2007-01-21 IL IL180846A patent/IL180846A0/en unknown
- 2007-01-25 CR CR8876A patent/CR8876A/es not_active Application Discontinuation
- 2007-01-26 EC EC2007007208A patent/ECSP077208A/es unknown
- 2007-02-21 MA MA29689A patent/MA28980B1/fr unknown
- 2007-02-27 NO NO20071107A patent/NO20071107L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MA28980B1 (fr) | 2007-11-01 |
| MX2007001188A (es) | 2007-03-21 |
| IL180846A0 (en) | 2007-06-03 |
| AR049847A1 (es) | 2006-09-06 |
| KR20070043985A (ko) | 2007-04-26 |
| ECSP077208A (es) | 2007-02-28 |
| NO20071107L (no) | 2007-04-19 |
| UA88018C2 (ru) | 2009-09-10 |
| RU2344134C2 (ru) | 2009-01-20 |
| BRPI0513793A (pt) | 2008-05-13 |
| ZA200700477B (en) | 2009-08-26 |
| CR8876A (es) | 2007-08-28 |
| RU2007107408A (ru) | 2008-09-10 |
| WO2006028590A1 (en) | 2006-03-16 |
| PE20060382A1 (es) | 2006-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL190730A0 (en) | Potassium channel inhibitors | |
| WO2006015159A3 (en) | Potassium channel inhibitors | |
| WO2005030791A3 (en) | Isoquinolinone potassium channel inhibitors | |
| WO2005030129A3 (en) | Quinoline potassium channel inhibitors | |
| WO2007050348A3 (en) | Potassium channel inhibitors | |
| WO2005046578A3 (en) | Isoquinolinone potassium channel inhibitors | |
| WO2005030130A3 (en) | Isoquinoline potassium channel inhibitors | |
| WO2007085895A3 (en) | Fap inhibitors | |
| MXPA05013553A (es) | Pirrolodihidroisoquinolinas como inhibidores de pde10. | |
| IL188452A0 (en) | 2,4-diamino-pyrimidines used as aurora inhibitors | |
| TW200621253A (en) | 2-amido-thiazole-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof | |
| MX2009006536A (es) | Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. | |
| TN2012000063A1 (en) | Quinazolines as potassium ion channel inhibitors | |
| TW200740429A (en) | Methods and dosage forms for reducing side effects of carbamate compounds | |
| EP1667685A4 (en) | INHIBITORS OF QUINAZOLINE-BASED POTASSIUM CANAL | |
| EA200701396A1 (ru) | Триазолофталазины в качестве ингибиторов pde-2 | |
| TW200744567A (en) | Phenylethylamine analogs and their use for treating glaucoma | |
| EP1667976A4 (en) | Isoquinolinone POTASSIUM CHANNEL INHIBITORS | |
| WO2006072612A3 (en) | Triazolophthalazines as pde2- inhibitors | |
| WO2005030792A3 (en) | Quinoline potassium channel inhibitors | |
| WO2007077329A3 (fr) | Nouvelle association d'un inhibiteur du courant if sinusoïdal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent | |
| MXPA06002315A (es) | Abridores de canal erg para el tratamiento de arritmias cardiacas. | |
| WO2006014877A3 (en) | Potassium channel inhibitors | |
| WO2005117543A3 (en) | N-sulfonylcarboximidamide apoptosis promoters | |
| WO2007062855A3 (en) | Radioimmunoconjugate for human cd66 for the treatment of multiple myeloma |